首页> 外国专利> CELL PENETRATING SHORT PEPTIDE TAT-HUR-HNS-3 AND APPLICATION THEREOF IN INFLAMMATORY DISEASE

CELL PENETRATING SHORT PEPTIDE TAT-HUR-HNS-3 AND APPLICATION THEREOF IN INFLAMMATORY DISEASE

机译:细胞穿透短肽TAT-HUN-HNS-3及其在炎性疾病中的应用

摘要

The present disclosure relates to a cell penetrating short peptide TAT-HuR-HNS-3 and application thereof in inflammatory disease, wherein the amino acid sequence of cell penetrating short peptide TAT-HuR-HNS-3 for inflammatory diseases caused by elevated inflammatory factors is YGRKKRRQRRR-SPMGVDHMSGLSGVNVPGNASSG, the inflammatory diseases caused by elevated inflammatory factors include lung inflammation, asthma, pollen allergy, and nephritis; TAT-HuR-HNS-3 may specifically inhibit the interaction of HuR-PARP1/HuR-HuR and the expression of inflammatory factors, and has no effect on cell proliferation and survival. This provides a safety guarantee for the drug development of cell penetrating peptides, and is a new method applied to the treatment of inflammatory diseases.
机译:本公开涉及一种细胞穿透短肽TAT-HUN-HNS-3及其在炎性疾病中的应用,其中细胞氨基酸序列穿透短肽TAT-HUR-HNS-3,用于由炎症因子升高引起的炎性疾病 YGRKKRRQRRR-SPMGVDHMSGRSGVNVPGNASSG,炎症因素升高引起的炎症疾病包括肺炎,哮喘,花粉过敏和肾炎; TAT-HUR-HNS-3可以特别抑制HUR-PARP1 / HUR-HUR的相互作用和炎症因子的表达,对细胞增殖和生存没有影响。 这为细胞穿透肽的药物开发提供了安全保障,并且是应用于炎症性疾病的新方法。

著录项

  • 公开/公告号US2021401929A1

    专利类型

  • 公开/公告日2021-12-30

    原文格式PDF

  • 申请/专利权人 NORTHEAST NORMAL UNIVERSITY;

    申请/专利号US202117142051

  • 发明设计人 XUEQING BA;YUESHUANG KE;KE WANG;

    申请日2021-01-05

  • 分类号A61K38/16;

  • 国家 US

  • 入库时间 2022-08-24 23:08:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号